Cytek Biosciences, Inc. (CTKB) net assets (shareholders' equity)

Net assets · fiscal 2025
$341.74M

Cytek Biosciences, Inc. (CTKB) had net assets of $341.74M at the end of fiscal 2025 (December 31, 2025). That is 13.6% lower than the $395.74M of fiscal 2024. Figures as of 18 Nov 2026, 18:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$341.74M
Change on fiscal 2024
−13.6%
Highest on record
$425.30Mfiscal 2022
Lowest on record
-$16.03Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cytek Biosciences, Inc. net assets (shareholders' equity), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $425.30M in fiscal 2022 and the lowest -$16.03M in fiscal 2020.

History · 6 fiscal years

Net assets by fiscal year

Cytek Biosciences, Inc. net assets (shareholders' equity), year by year

Cytek Biosciences, Inc. (CTKB) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$341.74M 13.6% down
2024$395.74M 0.7% up
2023$393.06M 7.6% down
2022$425.30M 4.9% up
2021$405.39M—
2020-$16.03M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on CTKB

Cytek Biosciences, Inc., figure by figure

Cytek Biosciences, Inc. (CTKB) overview: price, valuation and scorecard

Cytek Biosciences, Inc. net assets (shareholders' equity): questions and answers

What are Cytek Biosciences, Inc.'s net assets?

Cytek Biosciences, Inc. (CTKB) had net assets of $341.74M at the end of fiscal 2025 (December 31, 2025). That is 13.6% lower than the $395.74M of fiscal 2024.

What are the highest and lowest net assets figures on record for Cytek Biosciences, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $425.30M in fiscal 2022 and the lowest -$16.03M in fiscal 2020.

How is Cytek Biosciences, Inc.'s net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Cytek Biosciences, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytek Biosciences, Inc. (CTKB) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/CTKB/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.